Literature DB >> 35790449

[Progress in the study of antiviral activity of cepharanthine against SARS-CoV-2].

H Fan1, K Liu1, B Hong1, S He1, P Han1, M Li1, S Wang1, Y Tong1,2.   

Abstract

As a member of the dibenzyl isoquinoline alkaloid family, cepharathine is an alkaloid from the traditional Chinese medicine cepharathine, which is mainly used for treatment of leukopenia and other diseases. Recent studies of the inhibitory effect of cepharathine against SARS-CoV-2 have attracted widespread attention and aroused heated discussion. As the original discoverer of the anti-SARS-CoV-2 activity of cepharanthine, here we briefly summarize the discovery of cepharanthine and review important progress in relevant studies concerning the discovery and validation of anti-SARS-CoV-2 activity of cepharathine, its antiviral mechanisms and clinical trials of its applications in COVID-19 therapy.

Entities:  

Keywords:  SARS-CoV-2; cepharanthine; research progress

Mesh:

Substances:

Year:  2022        PMID: 35790449      PMCID: PMC9257352          DOI: 10.12122/j.issn.1673-4254.2022.06.22

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  14 in total

Review 1.  Thirteen bisbenzylisoquinoline alkaloids in five Chinese medicinal plants: Botany, traditional uses, phytochemistry, pharmacokinetic and toxicity studies.

Authors:  Han Zhang; Xiaoming Wang; Yaqing Guo; Xiaomei Liu; Xizi Zhao; Tekleab Teka; Chunxiao Lv; Lifeng Han; Yuhong Huang; Guixiang Pan
Journal:  J Ethnopharmacol       Date:  2020-11-07       Impact factor: 4.360

2.  Suppression of cytokine production and neural cell death by the anti-inflammatory alkaloid cepharanthine: a potential agent against HIV-1 encephalopathy.

Authors:  M Okamoto; M Ono; M Baba
Journal:  Biochem Pharmacol       Date:  2001-09-15       Impact factor: 5.858

3.  Synergistic inhibition of HTLV-1-infected cell proliferation by combination of cepharanthine and a tetramethylnaphthalene derivative.

Authors:  Masaaki Toyama; Takayuki Hamasaki; Tomofumi Uto; Hiroshi Aoyama; Mika Okamoto; Yuichi Hashmoto; Masanori Baba
Journal:  Anticancer Res       Date:  2012-07       Impact factor: 2.480

4.  Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins.

Authors:  Tommy Tsan-Yuk Lam; Na Jia; Ya-Wei Zhang; Marcus Ho-Hin Shum; Jia-Fu Jiang; Yi-Gang Tong; Hua-Chen Zhu; Yong-Xia Shi; Xue-Bing Ni; Yun-Shi Liao; Wen-Juan Li; Bao-Gui Jiang; Wei Wei; Ting-Ting Yuan; Kui Zheng; Xiao-Ming Cui; Jie Li; Guang-Qian Pei; Xin Qiang; William Yiu-Man Cheung; Lian-Feng Li; Fang-Fang Sun; Si Qin; Ji-Cheng Huang; Gabriel M Leung; Edward C Holmes; Yan-Ling Hu; Yi Guan; Wu-Chun Cao
Journal:  Nature       Date:  2020-03-26       Impact factor: 49.962

Review 5.  Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.

Authors:  Moshe Rogosnitzky; Paul Okediji; Igor Koman
Journal:  Pharmacol Rep       Date:  2020-07-22       Impact factor: 3.024

6.  Evaluating cepharanthine analogues as natural drugs against SARS-CoV-2.

Authors:  Atsushi Hijikata; Clara Shionyu-Mitsuyama; Setsu Nakae; Masafumi Shionyu; Motonori Ota; Shigehiko Kanaya; Takatsugu Hirokawa; Shogo Nakajima; Koichi Watashi; Tsuyoshi Shirai
Journal:  FEBS Open Bio       Date:  2021-12-09       Impact factor: 2.693

7.  Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2.

Authors:  Shaojun Zhang; Wenze Huang; Lili Ren; Xiaohui Ju; Mingli Gong; Jian Rao; Lei Sun; Pan Li; Qiang Ding; Jianwei Wang; Qiangfeng Cliff Zhang
Journal:  Cell Res       Date:  2021-11-04       Impact factor: 25.617

8.  Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.

Authors:  Nir Drayman; Jennifer K DeMarco; Krysten A Jones; Saara-Anne Azizi; Heather M Froggatt; Kemin Tan; Natalia Ivanovna Maltseva; Siquan Chen; Vlad Nicolaescu; Steve Dvorkin; Kevin Furlong; Rahul S Kathayat; Mason R Firpo; Vincent Mastrodomenico; Emily A Bruce; Madaline M Schmidt; Robert Jedrzejczak; Miguel Á Muñoz-Alía; Brooke Schuster; Vishnu Nair; Kyu-Yeon Han; Amornrat O'Brien; Anastasia Tomatsidou; Bjoern Meyer; Marco Vignuzzi; Dominique Missiakas; Jason W Botten; Christopher B Brooke; Hyun Lee; Susan C Baker; Bryan C Mounce; Nicholas S Heaton; William E Severson; Kenneth E Palmer; Bryan C Dickinson; Andrzej Joachimiak; Glenn Randall; Savaş Tay
Journal:  Science       Date:  2021-07-20       Impact factor: 63.714

9.  Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.

Authors:  Hua-Hao Fan; Li-Qin Wang; Wen-Li Liu; Xiao-Ping An; Zhen-Dong Liu; Xiao-Qi He; Li-Hua Song; Yi-Gang Tong
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

10.  Cepharanthine Suppresses Herpes Simplex Virus Type 1 Replication Through the Downregulation of the PI3K/Akt and p38 MAPK Signaling Pathways.

Authors:  Yao Liu; Li Chen; Wenjun Liu; Dan Li; Jiuseng Zeng; Qiong Tang; Yuexin Zhang; Fei Luan; Nan Zeng
Journal:  Front Microbiol       Date:  2021-12-09       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.